X and Y: Synthorx Expands the Genetic Code to Create Optimized Biologics

Advertisement

BEGIN ARTICLE PREVIEW:

GEN sat down with Marcos Milla, Ph.D., Chief Scientific Officer, and Lauren Baker, VP of Scientific & Medical Affairs, to discuss the history and future direction of Synthorx’s Expanded Genetic Alphabet platform technology. We also covered the company’s development since its recent acquisition by Sanofi . . .

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE